MedTrace Logo

Patient Perception and Clinical Efficacy of a Collagen Matrix for the Treatment of Peri-implantitis

NCT03551145 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-06-11

No results posted yet for this study

Summary

This is a multi-centre, randomized clinical trial which evaluates the efficiency of the collagen xenograft (Muco-Graft®) in comparison to the autologous connective tissue graft for the augmentation of keratinized mucosa and gaining hygienic access to the implants diagnosed with peri-implantitis.

Conditions

  • Peri-Implantitis

Interventions

OTHER

Acellular collagen matrix

3D collagen matrix consists of the collagen porcine type I and III

OTHER

Autogenous free gingival graft

Autogenous graft harvested from the posterior palate

Sponsors & Collaborators

  • PerioCentrum Research

    collaborator OTHER

  • Universidad Complutense de Madrid

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2019-12-01
Completion
2020-03-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03551145 on ClinicalTrials.gov